January 11, 2019
A drug that combines two antibodies protected ferrets and monkeys against the Bundibugyo, Sudan and Zaire strains of Ebola virus in a single dose, researchers reported in Cell Host & Microbe. The results suggest the drug would continue to offer protection as the virus evolves, says Thomas Geisbert, a professor at the University of Texas Medical Branch at Galveston.